These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

17 related articles for article (PubMed ID: 7754542)

  • 1. Targeting lonidamine to mitochondria mitigates lung tumorigenesis and brain metastasis.
    Cheng G; Zhang Q; Pan J; Lee Y; Ouari O; Hardy M; Zielonka M; Myers CR; Zielonka J; Weh K; Chang AC; Chen G; Kresty L; Kalyanaraman B; You M
    Nat Commun; 2019 May; 10(1):2205. PubMed ID: 31101821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lonidamine Induced Selective Acidification and De-Energization of Prostate Cancer Xenografts: Enhanced Tumor Response to Radiation Therapy.
    Orlovskiy S; Gupta PK; Roman J; Arias-Mendoza F; Nelson DS; Koch CJ; Narayan V; Putt ME; Nath K
    Cancers (Basel); 2024 Mar; 16(7):. PubMed ID: 38611062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ginsenoside Rg3 Serves as an Adjuvant Chemotherapeutic Agent and VEGF Inhibitor in the Treatment of Non-Small Cell Lung Cancer: A Meta-Analysis and Systematic Review.
    Xu T; Jin Z; Yuan Y; Wei H; Xu X; He S; Chen S; Hou W; Guo Q; Hua B
    Evid Based Complement Alternat Med; 2016; 2016():7826753. PubMed ID: 27800005
    [No Abstract]   [Full Text] [Related]  

  • 4. A phase II study of methotrexate, doxorubicin, cyclophosphamide, and lomustine chemotherapy and lonidamine in advanced non-small cell lung cancer.
    Buccheri G; Ferrigno D; Rosso A
    Cancer; 1993 Sep; 72(5):1564-72. PubMed ID: 8394198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomised trial of MACC chemotherapy with or without lonidamine in advanced non-small cell lung cancer. Cuneo Lung Cancer Study Group (CuLCaSG).
    Buccheri G; Ferrigno D
    Eur J Cancer; 1994; 30A(10):1424-31. PubMed ID: 7833096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cisplatin, epirubicin, and vindesine with or without lonidamine in the treatment of inoperable nonsmall cell lung carcinoma: a multicenter randomized clinical trial.
    Ianniello GP; De Cataldis G; Comella P; Scarpati MD; Maiorino A; Brancaccio L; Cioffi R; Lombardi A; Carnicelli P; Tinessa V
    Cancer; 1996 Jul; 78(1):63-9. PubMed ID: 8646728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of vindesine and lonidamine in the treatment of elderly patients with advanced non-small cell lung cancer: a phase III randomized FONICAP trial. Italian Lung Cancer Task Force.
    De Marinis F; Rinaldi M; Ardizzoni A; Bruzzi P; Pennucci MC; Portalone L; D'Aprile M; Ripanti P; Romano F; Belli M; Altavilla G; Migliorino MR; Rosso R; Salvati F
    Tumori; 1999; 85(3):177-82. PubMed ID: 10426128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Addition of either lonidamine or granulocyte colony-stimulating factor does not improve survival in early breast cancer patients treated with high-dose epirubicin and cyclophosphamide.
    Papaldo P; Lopez M; Cortesi E; Cammilluzzi E; Antimi M; Terzoli E; Lepidini G; Vici P; Barone C; Ferretti G; Di Cosimo S; Nistico C; Carlini P; Conti F; Di Lauro L; Botti C; Vitucci C; Fabi A; Giannarelli D; Marolla P
    J Clin Oncol; 2003 Sep; 21(18):3462-8. PubMed ID: 12972521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lonidamine plus cyclophosphamide in the treatment of adanced non-small cell lung cancer in the elderly: a phase II study.
    Salvati F; Antilli A; Cruciani AR; Lombardi A; Mugnaini L; Nunziati F; Perrone N; Portalone L; Signora M
    Tumori; 1995; 81(1):48-51. PubMed ID: 7754542
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 1.